Skip to main content
Maeve Waldron-Lynch, MD, Oncology, Hamden, CT

MaeveGeraldineWaldron-LynchMD

Oncology Hamden, CT

Physician

Dr. Waldron-Lynch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Waldron-Lynch's full profile

Already have an account?

  • Office

    Cambridge
    UK ( Doximity insists I use a US Zip!)
    Hamden, CT 06517

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
  • University College Cork Faculty of Medicine
    University College Cork Faculty of MedicineClass of 1999
  • University College Cork, National University of Ireland
    University College Cork, National University of IrelandB. Med. Sc., 1999

Awards, Honors, & Recognition

  • Pharmacia and Upjohn Gold Medal in Pharmacology School of Medicine, University College Cork, Ireland, 2000

Publications & Presentations

PubMed

Journal Articles

  • Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer  
    Edward B Garon, Maeve Waldron-Lynch, The New England Journal of Medicine
  • Prolonged Survival in a Patient with BRCA 2 associated Metastatic Pancreatic Cancer after exposure to Camptothecin: a case report and review of literature  
    James E, Waldron-Lynch M, Saif W M, Anti-Cancer Drugs, 1/8/2009
  • Biological Treatments in Breast Cancer-Editorial  
    M Waldron-Lynch, D Carney, J Mc Caffrey, Medicine Weekly (Irish medical periodical), 1/1/2006
  • Join now to see all

Abstracts/Posters

  • BERENICE: A two-cohort, Phase II, cardiac safety study of pertuzumab, trastuzumab, and neoadjuvant anthracyline based chemotherapy in patients with HER"-positive, loca...
    SM Swain, MS Ewer, H Douthwaite, T Szado, M Waldron-Lynch, C Dang, San Antonio Breast Cancer Symposium, 1/9/2014
  • A Single Institution Experience of Paraneoplastic Neurological Syndrome associated with Gynecological Cancers
    Waldron-Lynch M , Baehring JM, Abu-Khalaf M, American Academy of Neurology Annual Meeting, Honolulu, HI, 1/1/2011
  • Correlation of menopausal status and age with outcome in breast cancer patients in the West of Ireland.
    Waldron-Lynch M, McKeown D, Keane M, ASCO Meeting Proceedings, 1/1/2008
  • Join now to see all

Lectures

  • Targeting Breast Cancer Therapy 
    Cork, Ireland - 1/1/2007
  • Advances in Chemotherapeutics of Prostate Cancer 
    Galway, Ireland - 1/1/2005
  • Principles of Cancer Chemotherapy 
    Galway, Ireland - 1/1/2005

Authored Content

  • Long-Term Efficacy Analysis of the Randomised, Phase II TRYPHAENA Cardiac Safety Study: Evaluating Pertuzumab and Trastuzumab plus Standard Neoadjuvant Anthracycline-Containing and Anthracycline-Free Chemotherapy Regimens in Patients with HER2-Positive Early Breast CancerJanuary 2018
  • Long-Term Efficacy Analysis of the Randomised, Phase II TRYPHAENA Cardiac Safety Study: Evaluating Pertuzumab and Trastuzumab plus Standard Neoadjuvant Anthracycline-Containing and Anthracycline-Free Chemotherapy Regimens in Patients with HER2-Positive Early Breast CancerJanuary 2018